Search Results - "immunotherapy"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Compromising between European and US allergen immunotherapy schools: Discussions from GUIMIT, the Mexican immunotherapy guidelines by Larenas Linnemann, Désirée, Rodríguez Pérez, Noel, Luna Pech, Jorge A., Rodríguez González, Mónica, Blandón Vijil, María Virginia, Del Río Navarro, Blanca E., Costa Domínguez, María del Carmen, Navarrete Rodríguez, Elsy Maureen, Macouzet Sánchez, Carlos, Ortega Martell, José Antonio, Pozo Beltrán, César Fireth, Estrada Cardona, Alan, Arias Cruz, Alfredo, Rodríguez Galván, Karen Guadalupe, Brito Díaz, Herson, Canseco Raymundo, María Del Rosario, Castelán Chávez, Enrique Emanuel, Escalante Domínguez, Alberto José, Gálvez Romero, José Luis, Gómez Vera, Javier, González Díaz, Sandra Nora, Guerrero Núñez, María Gracia Belinda, Hernández Colín, Dante Daniel, Macías Weinmann, Alejandra, Mendoza Hernández, David Alejandro, Meneses Sánchez, Néstor Alejandro, Mogica Martínez, María Dolores, Moncayo Coello, Carol Vivian, Montiel Herrera, Juan Manuel, O'Farril Romanillos, Patricia María, Onuma Takane, Ernesto, Ortega Cisneros, Margarita, Rangel Garza, Lorena, Stone Aguilar, Héctor, Torres Lozano, Carlos, Venegas Montoya, Edna, Wakida Kusunoki, Guillermo, Partida Gaytán, Armando, López García, Aída Inés, Macías Robles, Ana Paola, Ambriz Moreno, María de Jesús, Azamar Jácome, Amyra Ali, Beltrán de Paz, Claudia Yusdivia, Caballero López, Chrystopherson, Fernández de Córdova Aguirre, Juan Carlos, Fernández Soto, José Roberto, Lozano Sáenz, José Santos, Oyoqui Flores, José Joel, Osorio Escamilla, Roberto Efrain, Ramírez Jiménez, Fernando, Rivero Yeverino, Daniela, Martínez Infante, Eric, Medina Ávalos, Miguel Alejandro

    Published 2020
    “…Background: Allergen immunotherapy (AIT) has a longstanding history and still remains the only disease-changing treatment for allergic rhinitis and asthma. …”
    Get full text
    Article
  2. 2

    100 years of immunotherapy: the Monaco charter by Canonica, Giorgio Walter, Baena Cagnani, Carlos E., Compalati, Enrico, Bohle, Barbara, Bonini, Sergio, Bousquet, Jean J., Cox, Linda, Fink Wagner, Antje H., González Díaz, Sandra Nora, Jacobsen, Lars, Passalacqua, Giovanni, Pawankar, Ruby, Vieths, Stefan, Yusuf, Osman M., Zuberbier, Torsten

    Published 2012
    “…Aims of the Monaco Charter: (1) to present the current evidence on the efficacy and safety of allergen-specific immunotherapy (SIT) and to address the reasons for its underuse in clinical practice; (2) to develop strategies to increase the awareness about the benefits and the hazards of SIT in allergic patients, lay public and healthcare professionals not trained in allergy, and (3) to make SIT accessible and affordable to eligible patients.…”
    Get full text
    Article
  3. 3
  4. 4
  5. 5

    Low dose of sublingual immunotherapy in patients with allergic rhinitis in a randomized double-blind placebocontrolled study by Leal Villarreal, Lucía, Huerta López, José G., Salinas Carmona, Mario César, Cárdenas Estrada, Eloy, Muñoz Espinosa, Linda Elsa, Castro Corona, María de los Ángeles, Medina de la Garza, Carlos Eduardo

    Published 2010
    “…Background: Few placebo controlled studies for sublingual immunotherapy (SLIT) have been performed so far in Latin America, and some issues like treatment scheme and doses remain uncertain Objective: to asses improvement in nasal, pharyngeal and ocular symptoms with low doses of SLIT to Dermatophagoides pteronyssinus comparing it with a placebo, in a Mexican population with allergic rhinitis (AR). …”
    Get full text
    Article
  6. 6

    Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma treated with cabozantinib and nivolumab by Salazar Mejía, Carlos Eduardo, Oyervides Juárez, Víctor Manuel, Wimer Castillo, Blanca Otilia, Vidal Gutiérrez, Oscar, Garza Guajardo, Raquel, Grande, Enrique

    Published 2020
    “…This is the first documented case of renal CT with a CDC component that obtained a partial response to combined treatment with immunotherapy and target therapy as first-line treatment; obtaining the longest overall survival reported in the setting of a metastatic renal CT with this histological combination. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Estudio del mecanismo de muerte celular inducido por el IMMUNEPOTENT CRP en combinación con ciclofosfamida en células de cáncer de mama by Rivera Lazarín, Ana Luisa

    Published 2020
    “…Current main proposes suggest the integration of immunotherapies in combined therapies in order to reduce the doses required for tumor eradication, to reduce adverse effects and to avoid treatment-resistance. …”
    Get full text
    Tesis
  14. 14

    Estudio del mecanismo de muerte celular inducido por el IMMUNEPOTENT CRP en combinación con ciclofosfamida en células de cáncer de mama by Rivera Lazarín, Ana Luisa

    Published 2020
    “…Current main proposes suggest the integration of immunotherapies in combined therapies in order to reduce the doses required for tumor eradication, to reduce adverse effects and to avoid treatment-resistance. …”
    Get full text
    Tesis
  15. 15

    Evaluación de la administración vía aerosol de la vacuna sintética basada en WT1-CPG en un modelo de cáncer pulmonar. by Arriaga Hernández, Daniela

    Published 2016
    “…Its restricted expression in normal tissue makes it an attractive target for cancer immunotherapy. The aim of this study is to determine whether an aerosolized peptide vaccine with WT1- specific T CD8+ and T CD4+ epitopes in combination with CpG is able to induce an effective antitumor response against a lung cancer B16F10 model. …”
    Get full text
    Tesis
  16. 16

    Evaluación de la administración vía aerosol de la vacuna sintética basada en WT1-CPG en un modelo de cáncer pulmonar. by Arriaga Hernández, Daniela

    Published 2016
    “…Its restricted expression in normal tissue makes it an attractive target for cancer immunotherapy. The aim of this study is to determine whether an aerosolized peptide vaccine with WT1- specific T CD8+ and T CD4+ epitopes in combination with CpG is able to induce an effective antitumor response against a lung cancer B16F10 model. …”
    Get full text
    Tesis

Search Tools: